Henning Zelba

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells

Benjamin Weide, Alexander Martens, Henning Zelba et al. · Clinical Cancer Research · 2013 · 257 citations

Medicine, Immunology, Oncology +17

High response rate after intratumoral treatment with interleukin‐2

Benjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder et al. · Cancer · 2010 · 141 citations · Full text

Life Sciences, Immunology, Oncology +14

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

Benjamin Weide, Henning Zelba, Evelyna Derhovanessian et al. · Journal of Clinical Oncology · 2012 · 117 citations · Full text

Life Sciences, Immunology, Oncology +17

Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people

Evelyna Derhovanessian, Andrea B. Maier, Karin Hähnel et al. · AGE · 2012 · 104 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma

Henning Zelba, Jens Bedke, Jörg Hennenlotter et al. · Cancer Immunology Research · 2019 · 102 citations · Full text

Life Sciences, Immunology, Oncology +17